PAVmed PAVMW 深 沪
等待开盘 05-15 09:30:00 美东时间
0.029
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.029
- 总市值 38.69万
- 52周最高 4.743
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.02
- 委 比 0.00%
- 总股本 1334.31万
- 历史最高 6.94
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.02
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PAVmed schedules quarterly business update call, to report Q1 results
PAVmed schedules quarterly business update call, to report Q1 results PAVmed scheduled first-quarter 2026 business update conference call and webcast for May 15, 2026 at 8:30 a.m. ET. CEO Lishan Aklog plans to outline operations update and growth strategy on May 15. President and CFO Dennis McGrath
05-01 20:36
Lucid Diagnostics Prices Underwritten Registered Direct Offering Of 18M Common Shares At $1.00 Per Share
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the pricing of an
04-23 20:36
PAVmed files Form 3 initial beneficial ownership statement for Tasso Partners LLC
PAVmed files Form 3 initial beneficial ownership statement for Tasso Partners LLC PAVmed Form 3 filing showed Tasso Partners held 912,996 shares of common stock as of March 27, 2026. Filing identified Tasso Partners as a 10% owner. Disclosure included warrants exercisable since Feb. 3, 2026, expirin
04-07 09:46
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio. Octeris, Inc. subsidiary formed to advance endoscopic esophagea...
04-02 20:01
PAVmed Reports 2025 Results, Strengthens Balance Sheet
An announcement from PAVmed ( ($PAVM) ) is now available. On March 30, 2026, PA...
03-30 21:11
PAVmed Non-GAAP EPS of -$1.05
PAVmed press release (PAVM): Q4 Non-GAAP EPS of -$1.05. PAVmed had cash and cash equivalents of $1.5 million as of December 31, 2025, compared to $1.2 million as of December 31, 2024. For the three mo...
03-30 20:11
Earnings Scheduled For March 30, 2026
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Lucid Diagnostics FY2025 revenue rises to $4.7 million; net loss widens to $58.0 million
Lucid Diagnostics FY2025 revenue rises to $4.7 million; net loss widens to $58.0 million PAVmed subsidiary Lucid Diagnostics reported it processed 3,664 EsoGuard tests and recognized USD 1.5 million in revenue. Lucid said it received a U.S. Department of Veterans Affairs contract for EsoGuard with M
03-26 20:05
PAVmed Inc. to Host Business Update Conference Call and Webcast
PAVmed Inc. to Host Business Update Conference Call and Webcast PAVmed will host a fourth quarter and full year 2025 business update conference call and webcast on March 30, 2026 at 8:30 AM ET. The webcast will be available on the investor relations section of pavmed.com at . Chairman and CEO Lishan
03-16 21:03
PAVmed Restructures Capital With New Preferred Financing
PAVmed ( ($PAVM) ) has issued an update. On February 3, 2026, PAVmed raised $30...
02-04 21:38
